As a novel target for cancer therapy, our study supports a role for DKK1 in treating AS further; thus, this may achieve the therapeutic purpose of "killing two birds with one stone" by simultaneously targeting tumors and inhibiting vascular lesions. This evidence concerns the gene DKK1 and cancer.